Previous Article | Next Article 
Journal of Virology, December 2003, p. 13376-13388, Vol. 77, No. 24
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.24.13376-13388.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences
Mark A. Jensen,1* Fu-Sheng Li,1,
Angélique B. van t Wout,1 David C. Nickle,1 Daniel Shriner,1 Hong-Xia He,1 Sherry McLaughlin,1 Raj Shankarappa,2 Joseph B. Margolick,3 and James I. Mullins1
Department
of Microbiology, University of Washington, Seattle, Washington
98195-8070,1
Allegheny-Singer Research
Institute, Pittsburgh, Pennsylvania,2
Department of Molecular
Microbiology and Immunology, School of Hygiene and Public
Health, The Johns Hopkins University, Baltimore,
Maryland3
Received 10 February 2003/
Accepted 11 September 2003
Early
in infection, human immunodeficiency virus type 1 (HIV-1) generally
uses the CCR5 chemokine receptor (along with CD4) for cellular entry.
In many HIV-1-infected individuals, viral genotypic changes arise that
allow the virus to use CXCR4 (either in addition to CCR5 or alone) as
an entry coreceptor. This switch has been associated with an
acceleration of both CD3+ T-cell decline and
progression to AIDS. While it is well known that the V3 loop of gp120
largely determines coreceptor usage and that positively charged
residues in V3 play an important role, the process of genetic change in
V3 leading to altered coreceptor usage is not well understood. Further,
the methods for biological phenotyping of virus for research or
clinical purposes are laborious, depend on sample availability, and
present biosafety concerns, so reliable methods for sequence-based
"virtual phenotyping" are desirable. We introduce a
simple bioinformatic method of scoring V3 amino acid sequences that
reliably predicts CXCR4 usage (sensitivity, 84%; specificity,
96%). This score (as determined on the basis of
position-specific scoring matrices [PSSM]) can be interpreted
as revealing a propensity to use CXCR4 as follows: known R5 viruses had
low scores, R5X4 viruses had intermediate scores, and X4 viruses had
high scores. Application of the PSSM scoring method to reconstructed
virus phylogenies of 11 longitudinally sampled individuals revealed
that the development of X4 viruses was generally gradual and involved
the accumulation of multiple amino acid changes in V3. We found that X4
viruses were lost in two ways: by the dying off of an established X4
lineage or by mutation back to low-scoring V3
loops.
* Corresponding
author. Mailing address: Department of Microbiology, University of
Washington School of Medicine, Seattle, WA 98195-8070. Phone: (206)
732-6102. Fax: (206) 732-6167. E-mail:
majensen{at}u.washington.edu.
Present
address: Fred Hutchinson Cancer Research Center, MW-500, Seattle, WA
98109.
Journal of Virology, December 2003, p. 13376-13388, Vol. 77, No. 24
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.24.13376-13388.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Del Prete, G. Q., Haggarty, B., Leslie, G. J., Jordan, A. P. O., Romano, J., Wang, N., Wang, J., Holmes, M. C., Montefiori, D. C., Hoxie, J. A.
(2009). Derivation and Characterization of a Simian Immunodeficiency Virus SIVmac239 Variant with Tropism for CXCR4. J. Virol.
83: 9911-9922
[Abstract]
[Full Text]
-
Etemad, B., Fellows, A., Kwambana, B., Kamat, A., Feng, Y., Lee, S., Sagar, M.
(2009). Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection. J. Virol.
83: 9694-9708
[Abstract]
[Full Text]
-
Raymond, S., Delobel, P., Mavigner, M., Cazabat, M., Souyris, C., Encinas, S., Sandres-Saune, K., Pasquier, C., Marchou, B., Massip, P., Izopet, J.
(2009). Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism. J. Clin. Microbiol.
47: 2292-2294
[Abstract]
[Full Text]
-
Gray, L., Roche, M., Churchill, M. J., Sterjovski, J., Ellett, A., Poumbourios, P., Sheffief, S., Wang, B., Saksena, N., Purcell, D. F. J., Wesselingh, S., Cunningham, A. L., Brew, B. J., Gabuzda, D., Gorry, P. R.
(2009). Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain. J. Virol.
83: 5430-5441
[Abstract]
[Full Text]
-
Ince, W. L., Harrington, P. R., Schnell, G. L., Patel-Chhabra, M., Burch, C. L., Menezes, P., Price, R. W., Eron, J. J. Jr., Swanstrom, R. I.
(2009). Major Coexisting Human Immunodeficiency Virus Type 1 env Gene Subpopulations in the Peripheral Blood Are Produced by Cells with Similar Turnover Rates and Show Little Evidence of Genetic Compartmentalization. J. Virol.
83: 4068-4080
[Abstract]
[Full Text]
-
Poveda, E., Seclen, E., Gonzalez, M. d. M., Garcia, F., Chueca, N., Aguilera, A., Rodriguez, J. J., Gonzalez-Lahoz, J., Soriano, V.
(2009). Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists. J Antimicrob Chemother
63: 1006-1010
[Abstract]
[Full Text]
-
Schnell, G., Ince, W. L., Swanstrom, R.
(2008). Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes. Nucleic Acids Res
36: e146-e146
[Abstract]
[Full Text]
-
Coetzer, M., Nedellec, R., Salkowitz, J., McLaughlin, S., Liu, Y., Heath, L., Mullins, J. I., Mosier, D. E.
(2008). Evolution of CCR5 Use before and during Coreceptor Switching. J. Virol.
82: 11758-11766
[Abstract]
[Full Text]
-
Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Boni, J., Hirschel, B., Weber, R., Trkola, A., Gunthard, H. F., The Swiss HIV Cohort Study,
(2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl. Acad. Sci. USA
105: 16725-16730
[Abstract]
[Full Text]
-
Miura, T., Brockman, M. A., Brumme, C. J., Brumme, Z. L., Carlson, J. M., Pereyra, F., Trocha, A., Addo, M. M., Block, B. L., Rothchild, A. C., Baker, B. M., Flynn, T., Schneidewind, A., Li, B., Wang, Y. E., Heckerman, D., Allen, T. M., Walker, B. D.
(2008). Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes. J. Virol.
82: 8422-8430
[Abstract]
[Full Text]
-
Huang, W., Toma, J., Fransen, S., Stawiski, E., Reeves, J. D., Whitcomb, J. M., Parkin, N., Petropoulos, C. J.
(2008). Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein. J. Virol.
82: 5584-5593
[Abstract]
[Full Text]
-
Garrido, C., Roulet, V., Chueca, N., Poveda, E., Aguilera, A., Skrabal, K., Zahonero, N., Carlos, S., Garcia, F., Faudon, J. L., Soriano, V., de Mendoza, C.
(2008). Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes. J. Clin. Microbiol.
46: 887-891
[Abstract]
[Full Text]
-
Briz, V., Poveda, E., del Mar Gonzalez, M., Martin-Carbonero, L., Gonzalez-Gonzalez, R., Soriano, V.
(2008). Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years. J Antimicrob Chemother
61: 405-410
[Abstract]
[Full Text]
-
Nolan, K. M., Jordan, A. P. O., Hoxie, J. A.
(2008). Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors. J. Virol.
82: 664-673
[Abstract]
[Full Text]
-
Patel, M. B., Hoffman, N. G., Swanstrom, R.
(2008). Subtype-Specific Conformational Differences within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Proteins. J. Virol.
82: 903-916
[Abstract]
[Full Text]
-
Milush, J. M., Reeves, J. D., Gordon, S. N., Zhou, D., Muthukumar, A., Kosub, D. A., Chacko, E., Giavedoni, L. D., Ibegbu, C. C., Cole, K. S., Miamidian, J. L., Paiardini, M., Barry, A. P., Staprans, S. I., Silvestri, G., Sodora, D. L.
(2007). Virally Induced CD4+ T Cell Depletion Is Not Sufficient to Induce AIDS in a Natural Host. J. Immunol.
179: 3047-3056
[Abstract]
[Full Text]
-
Huang, W., Eshleman, S. H., Toma, J., Fransen, S., Stawiski, E., Paxinos, E. E., Whitcomb, J. M., Young, A. M., Donnell, D., Mmiro, F., Musoke, P., Guay, L. A., Jackson, J. B., Parkin, N. T., Petropoulos, C. J.
(2007). Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations. J. Virol.
81: 7885-7893
[Abstract]
[Full Text]
-
Billington, J., Hickling, T. P., Munro, G. H., Halai, C., Chung, R., Dodson, G. G., Daniels, R. S.
(2007). Stability of a Receptor-Binding Active Human Immunodeficiency Virus Type 1 Recombinant gp140 Trimer Conferred by Intermonomer Disulfide Bonding of the V3 Loop: Differential Effects of Protein Disulfide Isomerase on CD4 and Coreceptor Binding. J. Virol.
81: 4604-4614
[Abstract]
[Full Text]
-
Delobel, P., Nugeyre, M.-T., Cazabat, M., Pasquier, C., Marchou, B., Massip, P., Barre-Sinoussi, F., Israel, N., Izopet, J.
(2007). Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies. J. Clin. Microbiol.
45: 1572-1580
[Abstract]
[Full Text]
-
Kiselyeva, Y., Nedellec, R., Ramos, A., Pastore, C., Margolis, L. B., Mosier, D. E.
(2007). Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations. J. Virol.
81: 3657-3661
[Abstract]
[Full Text]
-
Mild, M., Esbjornsson, J., Fenyo, E. M., Medstrand, P.
(2007). Frequent Intrapatient Recombination between Human Immunodeficiency Virus Type 1 R5 and X4 Envelopes: Implications for Coreceptor Switch. J. Virol.
81: 3369-3376
[Abstract]
[Full Text]
-
Goodenow, M. M., Collman, R. G.
(2006). HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J. Leukoc. Biol.
80: 965-972
[Abstract]
[Full Text]
-
Fernandez, G., Llano, A., Esgleas, M., Clotet, B., Este, J. A., Martinez, M. A.
(2006). Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.. J. Gen. Virol.
87: 1285-1294
[Abstract]
[Full Text]
-
Jensen, M. A., Coetzer, M., van 't Wout, A. B., Morris, L., Mullins, J. I.
(2006). A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope v3 sequences.. J. Virol.
80: 4698-4704
[Abstract]
[Full Text]
-
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., van der Ryst, E.
(2006). Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir.. J. Virol.
80: 4909-4920
[Abstract]
[Full Text]
-
Cicala, C., Arthos, J., Martinelli, E., Censoplano, N., Cruz, C. C., Chung, E., Selig, S. M., Van Ryk, D., Yang, J., Jagannatha, S., Chun, T. W., Ren, P., Lempicki, R. A., Fauci, A. S.
(2006). R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. Proc. Natl. Acad. Sci. USA
103: 3746-3751
[Abstract]
[Full Text]
-
Clevestig, P., Pramanik, L., Leitner, T., Ehrnst, A.
(2006). CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site.. J. Gen. Virol.
87: 607-612
[Abstract]
[Full Text]
-
Charpentier, C., Nora, T., Tenaillon, O., Clavel, F., Hance, A. J.
(2006). Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients. J. Virol.
80: 2472-2482
[Abstract]
[Full Text]
-
Watabe, T., Kishino, H., Okuhara, Y., Kitazoe, Y.
(2006). Fold Recognition of the Human Immunodeficiency Virus Type 1 V3 Loop and Flexibility of Its Crown Structure During the Course of Adaptation to a Host. Genetics
172: 1385-1396
[Abstract]
[Full Text]
-
Pastore, C., Nedellec, R., Ramos, A., Pontow, S., Ratner, L., Mosier, D. E.
(2006). Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations. J. Virol.
80: 750-758
[Abstract]
[Full Text]
-
Blay, W.M., Gnanakaran, S., Foley, B., Doria-Rose, N. A., Korber, B. T., Haigwood, N. L.
(2006). Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques. J. Virol.
80: 999-1014
[Abstract]
[Full Text]
-
Ghaffari, G., Tuttle, D. L., Briggs, D., Burkhardt, B. R., Bhatt, D., Andiman, W. A., Sleasman, J. W., Goodenow, M. M.
(2005). Complex Determinants in Human Immunodeficiency Virus Type 1 Envelope gp120 Mediate CXCR4-Dependent Infection of Macrophages. J. Virol.
79: 13250-13261
[Abstract]
[Full Text]
-
Beerenwinkel, N., Sing, T., Lengauer, T., Rahnenfuhrer, J., Roomp, K., Savenkov, I., Fischer, R., Hoffmann, D., Selbig, J., Korn, K., Walter, H., Berg, T., Braun, P., Fatkenheuer, G., Oette, M., Rockstroh, J., Kupfer, B., Kaiser, R., Daumer, M.
(2005). Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics
21: 3943-3950
[Abstract]
[Full Text]
-
Doria-Rose, N. A., Learn, G. H., Rodrigo, A. G., Nickle, D. C., Li, F., Mahalanabis, M., Hensel, M. T., McLaughlin, S., Edmonson, P. F., Montefiori, D., Barnett, S. W., Haigwood, N. L., Mullins, J. I.
(2005). Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope. J. Virol.
79: 11214-11224
[Abstract]
[Full Text]
-
Troyer, R. M., Collins, K. R., Abraha, A., Fraundorf, E., Moore, D. M., Krizan, R. W., Toossi, Z., Colebunders, R. L., Jensen, M. A., Mullins, J. I., Vanham, G., Arts, E. J.
(2005). Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression. J. Virol.
79: 9006-9018
[Abstract]
[Full Text]
-
Lusso, P., Earl, P. L., Sironi, F., Santoro, F., Ripamonti, C., Scarlatti, G., Longhi, R., Berger, E. A., Burastero, S. E.
(2005). Cryptic Nature of a Conserved, CD4-Inducible V3 Loop Neutralization Epitope in the Native Envelope Glycoprotein Oligomer of CCR5-Restricted, but Not CXCR4-Using, Primary Human Immunodeficiency Virus Type 1 Strains. J. Virol.
79: 6957-6968
[Abstract]
[Full Text]
-
Bupp, K., Sarangi, A., Roth, M. J.
(2005). Probing Sequence Variation in the Receptor-Targeting Domain of Feline Leukemia Virus Envelope Proteins with Peptide Display Libraries. J. Virol.
79: 1463-1469
[Abstract]
[Full Text]
-
Karlsson, I., Antonsson, L., Shi, Y., Oberg, M., Karlsson, A., Albert, J., Olde, B., Owman, C., Jansson, M., Fenyo, E. M.
(2004). Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype. J. Virol.
78: 11807-11815
[Abstract]
[Full Text]
-
Marozsan, A. J., Fraundorf, E., Abraha, A., Baird, H., Moore, D., Troyer, R., Nankja, I., Arts, E. J.
(2004). Relationships between Infectious Titer, Capsid Protein Levels, and Reverse Transcriptase Activities of Diverse Human Immunodeficiency Virus Type 1 Isolates. J. Virol.
78: 11130-11141
[Abstract]
[Full Text]
-
Potter, S. J., Lemey, P., Achaz, G., Chew, C. B., Vandamme, A.-M., Dwyer, D. E., Saksena, N. K.
(2004). HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J. Leukoc. Biol.
76: 562-570
[Abstract]
[Full Text]
-
Pastore, C., Ramos, A., Mosier, D. E.
(2004). Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching. J. Virol.
78: 7565-7574
[Abstract]
[Full Text]